Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 272

1.

Radio-guided and clip-guided preoperative localization for malignant microcalcifications offer similar performances in breast-conserving surgery.

Corsi F, Bossi D, Sartani A, Papadopoulou O, Amadori R, Scoccia E, Trifirò G, Albasini S, Truffi M, Bonizzi A, Sorrentino L.

Breast J. 2019 Jun 11. doi: 10.1111/tbj.13354. [Epub ahead of print]

PMID:
31187568
2.

Inflammatory Bowel Disease Onset During Secukinumab Treatment: Real Concern or Just an Expression of Dysregulated Immune Response?

Fries W, Belvedere A, Cappello M, Orlando A, Trifirò G.

Clin Drug Investig. 2019 Jun 6. doi: 10.1007/s40261-019-00803-7. [Epub ahead of print]

PMID:
31168691
3.

Role of healthcare databases and registries for surveillance of orphan drugs in the real-world setting: the Italian case study.

Crisafulli S, Sultana J, Ingrasciotta Y, Addis A, Cananzi P, Cavagna L, Conter V, D'Angelo G, Ferrajolo C, Mantovani L, Pastorello M, Scondotto S, Trifirò G.

Expert Opin Drug Saf. 2019 Jun;18(6):497-509. doi: 10.1080/14740338.2019.1614165. Epub 2019 May 22. Review.

PMID:
31059293
4.

Prognostic Value of 18F-Fluorocholine PET Parameters in Metastatic Castrate-Resistant Prostate Cancer Patients Treated with Docetaxel.

Quaquarini E, D'Ambrosio D, Sottotetti F, Gallivanone F, Hodolic M, Baiardi P, Palumbo R, Vellani C, Canevari C, Bernardo A, Castiglioni I, Porta C, Trifirò G.

Contrast Media Mol Imaging. 2019 Mar 26;2019:4325946. doi: 10.1155/2019/4325946. eCollection 2019.

5.

Management of cancer-associated anemia with erythropoiesis-stimulating agents: ASCO/ASH clinical practice guideline update.

Bohlius J, Bohlke K, Castelli R, Djulbegovic B, Lustberg MB, Martino M, Mountzios G, Peswani N, Porter L, Tanaka TN, Trifirò G, Yang H, Lazo-Langner A.

Blood Adv. 2019 Apr 23;3(8):1197-1210. doi: 10.1182/bloodadvances.2018030387. Review.

6.

Management of Cancer-Associated Anemia With Erythropoiesis-Stimulating Agents: ASCO/ASH Clinical Practice Guideline Update.

Bohlius J, Bohlke K, Castelli R, Djulbegovic B, Lustberg MB, Martino M, Mountzios G, Peswani N, Porter L, Tanaka TN, Trifirò G, Yang H, Lazo-Langner A.

J Clin Oncol. 2019 May 20;37(15):1336-1351. doi: 10.1200/JCO.18.02142. Epub 2019 Apr 10.

PMID:
30969847
7.

Real-world insights on the management of migraine patients: an Italian nationwide study.

Agostoni E, Barbanti P, Frediani F, Trifirò G, Burgio L, di Nola L, Pegoraro V, Pulimeno S, Cepparulo M.

Curr Med Res Opin. 2019 Mar 29:1-10. doi: 10.1080/03007995.2019.1602032. [Epub ahead of print]

PMID:
30924392
8.

Antipsychotic utilization patterns among patients with schizophrenic disorder: a cross-national analysis in four countries.

Sultana J, Hurtado I, Bejarano-Quisoboni D, Giorgianni F, Huybrechts KF, Lu Z, Patorno E, Sanfélix-Gimeno G, Tari DU, Trifirò G.

Eur J Clin Pharmacol. 2019 Mar 1. doi: 10.1007/s00228-019-02654-9. [Epub ahead of print]

PMID:
30824947
9.

Gender Differences in Outpatient Pediatric Drug Utilization: A Cohort Study From Southern Italy.

Ferrajolo C, Sultana J, Ientile V, Scavone C, Scondotto G, Tari M, Trifirò G, Rossi F, Capuano A.

Front Pharmacol. 2019 Feb 5;10:11. doi: 10.3389/fphar.2019.00011. eCollection 2019.

10.

Radio-guided vs clip-guided localization of nonpalpable mass-like lesions of the breast from a screened population: A propensity score-matched study.

Corsi F, Bossi D, Combi F, Papadopoulou O, Amadori R, Regolo L, Trifirò G, Albasini S, Mazzucchelli S, Sorrentino L.

J Surg Oncol. 2019 Jun;119(7):916-924. doi: 10.1002/jso.25409. Epub 2019 Feb 11.

11.

Patterns and trends of utilization of incretin-based medicines between 2008 and 2014 in three Italian geographic areas.

Roberto G, Barone-Adesi F, Giorgianni F, Pizzimenti V, Ferrajolo C, Tari M, Bartolini C, Da Cas R, Maggini M, Spila-Alegiani S, Francesconi P, Trifirò G, Poluzzi E, Baccetti F, Gini R.

BMC Endocr Disord. 2019 Feb 7;19(1):18. doi: 10.1186/s12902-019-0334-y.

12.

Role of Cerebrospinal Fluid Biomarkers and (18)F-florbetapir PET Imaging in the Diagnosis of Primary Progressive Aphasia: A Retrospective Analysis.

Perini G, Cotta Ramusino M, Sinforiani E, Franciotta D, Trifirò G, Ceroni M, Costa A.

Alzheimer Dis Assoc Disord. 2019 Jan 10. doi: 10.1097/WAD.0000000000000289. [Epub ahead of print]

PMID:
30640253
13.

Identifying Data Elements to Measure Frailty in a Dutch Nationwide Electronic Medical Record Database for Use in Postmarketing Safety Evaluation: An Exploratory Study.

Sultana J, Leal I, de Wilde M, de Ridder M, van der Lei J, Sturkenboom M, Trifiro' G.

Drug Saf. 2019 Jun;42(6):713-719. doi: 10.1007/s40264-018-00785-z.

PMID:
30617499
14.

All-cause mortality and antipsychotic use among elderly persons with high baseline cardiovascular and cerebrovascular risk: a multi-center retrospective cohort study in Italy.

Sultana J, Giorgianni F, Rea F, Lucenteforte E, Lombardi N, Mugelli A, Vannacci A, Liperoti R, Kirchmayer U, Vitale C, Chinellato A, Roberto G, Corrao G, Trifirò G.

Expert Opin Drug Metab Toxicol. 2019 Feb;15(2):179-188. doi: 10.1080/17425255.2019.1561860. Epub 2019 Jan 4.

PMID:
30572727
15.

Workshop on the Italian Pharmacovigilance System in the International Context: Critical Issues and Perspectives.

Sultana J, Moretti U, Addis A, Caduff P, Capuano A, Kant A, Laporte JR, Lindquist M, Raine J, Sartori D, Trifirò G, Tuccori M, Venegoni M, van Puijenbroek E, Leone R.

Drug Saf. 2019 May;42(5):683-687. doi: 10.1007/s40264-018-0768-6. No abstract available.

PMID:
30565019
16.

Monitoring response of advanced Merkel cell carcinoma to Avelumab with 18F-FDG PET/CT.

Vellani C, D'Ambrosio D, Licata L, Vacchieri I, Bernardo A, Trifirò G.

Eur J Nucl Med Mol Imaging. 2019 May;46(5):1197-1198. doi: 10.1007/s00259-018-4230-x. Epub 2018 Dec 7. No abstract available.

PMID:
30535745
17.

Pharmacokinetics of new oral anticoagulants: implications for use in routine care.

Ingrasciotta Y, Crisafulli S, Pizzimenti V, Marcianò I, Mancuso A, Andò G, Corrao S, Capranzano P, Trifirò G.

Expert Opin Drug Metab Toxicol. 2018 Oct;14(10):1057-1069. doi: 10.1080/17425255.2018.1530213. Review.

PMID:
30277082
18.

Parameters Influencing PET Imaging Features: A Phantom Study with Irregular and Heterogeneous Synthetic Lesions.

Gallivanone F, Interlenghi M, D'Ambrosio D, Trifirò G, Castiglioni I.

Contrast Media Mol Imaging. 2018 Sep 10;2018:5324517. doi: 10.1155/2018/5324517. eCollection 2018.

19.

The Role of European Healthcare Databases for Post-Marketing Drug Effectiveness, Safety and Value Evaluation: Where Does Italy Stand?

Trifirò G, Gini R, Barone-Adesi F, Beghi E, Cantarutti A, Capuano A, Carnovale C, Clavenna A, Dellagiovanna M, Ferrajolo C, Franchi M, Ingrasciotta Y, Kirchmayer U, Lapi F, Leone R, Leoni O, Lucenteforte E, Moretti U, Mugelli A, Naldi L, Poluzzi E, Rafaniello C, Rea F, Sultana J, Tettamanti M, Traversa G, Vannacci A, Mantovani L, Corrao G.

Drug Saf. 2019 Mar;42(3):347-363. doi: 10.1007/s40264-018-0732-5. Review.

PMID:
30269245
20.

Could radiotherapy play a major role in misidentification of sentinel lymph node in breast cancer recurrence?

Lissidini G, Trifirò G, Veronesi P, Grana C, Zurrida S, Galimberti V, Corso G, Vellani C, Ivaldi GB.

Radiother Oncol. 2019 Feb;131:237-238. doi: 10.1016/j.radonc.2018.08.001. Epub 2018 Aug 30.

PMID:
30174108
21.

PETC/CT with 18F-Choline localizes hyperfunctioning parathyroid adenomas equally well in normocalcemic hyperparathyroidism as in overt hyperparathyroidism.

Bossert I, Chytiris S, Hodolic M, Croce L, Mansi L, Chiovato L, Mariani G, Trifirò G.

J Endocrinol Invest. 2019 Apr;42(4):419-426. doi: 10.1007/s40618-018-0931-z. Epub 2018 Aug 9.

PMID:
30094743
22.

Diagnosis, treatment and prevention of pediatric obesity: consensus position statement of the Italian Society for Pediatric Endocrinology and Diabetology and the Italian Society of Pediatrics.

Valerio G, Maffeis C, Saggese G, Ambruzzi MA, Balsamo A, Bellone S, Bergamini M, Bernasconi S, Bona G, Calcaterra V, Canali T, Caroli M, Chiarelli F, Corciulo N, Crinò A, Di Bonito P, Di Pietrantonio V, Di Pietro M, Di Sessa A, Diamanti A, Doria M, Fintini D, Franceschi R, Franzese A, Giussani M, Grugni G, Iafusco D, Iughetti L, Lamborghini A, Licenziati MR, Limauro R, Maltoni G, Manco M, Reggiani LM, Marcovecchio L, Marsciani A, Del Giudice EM, Morandi A, Morino G, Moro B, Nobili V, Perrone L, Picca M, Pietrobelli A, Privitera F, Purromuto S, Ragusa L, Ricotti R, Santamaria F, Sartori C, Stilli S, Street ME, Tanas R, Trifiró G, Umano GR, Vania A, Verduci E, Zito E.

Ital J Pediatr. 2018 Jul 31;44(1):88. doi: 10.1186/s13052-018-0525-6. Review.

23.

The economic burden of preventable adverse drug reactions: a systematic review of observational studies.

Formica D, Sultana J, Cutroneo PM, Lucchesi S, Angelica R, Crisafulli S, Ingrasciotta Y, Salvo F, Spina E, Trifirò G.

Expert Opin Drug Saf. 2018 Jul;17(7):681-695. doi: 10.1080/14740338.2018.1491547. Epub 2018 Jul 3. Review.

PMID:
29952667
24.

Long-Term Intravitreal Ranibizumab as a Potential Additional Risk Factor for Neurodegeneration in Parkinson's Disease: A Case Report.

Trifirò G, Marcianò I, Cutroneo PM, Spina E, Mirabelli E, Trombetta CJ, Morgante F.

Front Pharmacol. 2018 Jun 8;9:608. doi: 10.3389/fphar.2018.00608. eCollection 2018.

25.

Can Electronic Health Records Databases Complement Spontaneous Reporting System Databases? A Historical-Reconstruction of the Association of Rofecoxib and Acute Myocardial Infarction.

Patadia VK, Schuemie MJ, Coloma PM, Herings R, van der Lei J, Sturkenboom M, Trifirò G.

Front Pharmacol. 2018 Jun 6;9:594. doi: 10.3389/fphar.2018.00594. eCollection 2018.

26.

Epidemiology of acromegaly in Italy: analysis from a large longitudinal primary care database.

Gatto F, Trifirò G, Lapi F, Cocchiara F, Campana C, Dell'Aquila C, Ferrajolo C, Arvigo M, Cricelli C, Giusti M, Ferone D.

Endocrine. 2018 Sep;61(3):533-541. doi: 10.1007/s12020-018-1630-4. Epub 2018 May 24.

PMID:
29797214
27.

Safety of Biologics, Including Biosimilars: Perspectives on Current Status and Future Direction.

Ingrasciotta Y, Cutroneo PM, Marcianò I, Giezen T, Atzeni F, Trifirò G.

Drug Saf. 2018 Nov;41(11):1013-1022. doi: 10.1007/s40264-018-0684-9. Review.

PMID:
29796832
28.

Bleeding events attributable to concurrent use of warfarin and other medications in high-risk elderly: meta-analysis and Italian population-based investigation.

Comoretto RI, Rea F, Lucenteforte E, Mugelli A, Trifirò G, Cascini S, Roberto G, Chinellato A, Filippelli A, Corrao G; Italian Group for Appropriate Drug prescription in the Elderly (I-GrADE).

Eur J Clin Pharmacol. 2018 Aug;74(8):1061-1070. doi: 10.1007/s00228-018-2467-8. Epub 2018 May 7.

PMID:
29736825
29.

Pattern of Use of Biosimilar and Originator Somatropin in Italy: A Population-Based Multiple Databases Study During the Years 2009-2014.

Marcianò I, Ingrasciotta Y, Giorgianni F, Ientile V, Chinellato A, Tari DU, Gini R, Cannavò S, Pastorello M, Scondotto S, Cananzi P, Traversa G, Trotta F, Belleudi V, Addis A, Trifirò G.

Front Endocrinol (Lausanne). 2018 Mar 13;9:95. doi: 10.3389/fendo.2018.00095. eCollection 2018.

30.

Real world use of biological drugs in patients with psoriasis/psoriatic arthritis: a retrospective, population-based study from Southern Italy in the years 2010-2014.

Marcianò I, Randazzo MP, Panagia P, Intelisano R, Sgroi C, Ientile V, Cannavò S, Guarneri C, Reitano P, Spina E, Trifirò G.

G Ital Dermatol Venereol. 2018 Mar 26. doi: 10.23736/S0392-0488.18.05753-X. [Epub ahead of print]

PMID:
29582617
31.

Improvement in the management of chronic obstructive pulmonary disease following a clinical educational program: results from a prospective cohort study in the Sicilian general practice setting.

Ferrara R, Ientile V, Piccinni C, Pasqua A, Pecchioli S, Fontana A, Alecci U, Scoglio R, Magliozzo F, Torrisi SE, Vancheri C, Vitulo P, Fantaci G, Ferrajolo C, Cazzola M, Cricelli C, Caputi AP, Trifirò G.

NPJ Prim Care Respir Med. 2018 Mar 23;28(1):10. doi: 10.1038/s41533-018-0077-7.

32.

NSAIDs utilization for musculoskeletal indications in elderly patients with cerebro/cardiovascular disease.

Roberto G, Bartolini C, Rea F, Onder G, Vitale C, Trifirò G, Kirchmayer U, Chinellato A, Lucenteforte E, Corrao G, Mugelli A, Lapi F, Gini R; Italian Group for Appropriate Drug prescription in the Elderly (I-GrADE).

Eur J Clin Pharmacol. 2018 May;74(5):637-643. doi: 10.1007/s00228-018-2411-y. Epub 2018 Jan 30.

33.

Can information on functional and cognitive status improve short-term mortality risk prediction among community-dwelling older people? A cohort study using a UK primary care database.

Sultana J, Fontana A, Giorgianni F, Basile G, Patorno E, Pilotto A, Molokhia M, Stewart R, Sturkenboom M, Trifirò G.

Clin Epidemiol. 2017 Dec 19;10:31-39. doi: 10.2147/CLEP.S145530. eCollection 2018.

34.

Author Correction to: Prevalence of Use and Cost of Biological Drugs for Cancer Treatment: A 5-Year Picture from Southern Italy.

Lucchesi S, Marcianò I, Panagia P, Intelisano R, Randazzo MP, Sgroi C, Altavilla G, Santarpia M, Adamo V, Franchina T, Ferraù F, Reitano P, Trifirò G.

Clin Drug Investig. 2018 Mar;38(3):279-285. doi: 10.1007/s40261-017-0613-1.

35.

Policies for biosimilar uptake in Europe: An overview.

Moorkens E, Vulto AG, Huys I, Dylst P, Godman B, Keuerleber S, Claus B, Dimitrova M, Petrova G, Sović-Brkičić L, Slabý J, Šebesta R, Laius O, Karr A, Beck M, Martikainen JE, Selke GW, Spillane S, McCullagh L, Trifirò G, Vella Bonanno P, Mack A, Fogele A, Viksna A, Władysiuk M, Mota-Filipe H, Meshkov D, Kalaba M, Mencej Bedrač S, Fürst J, Zara C, Skiöld P, Magnússon E, Simoens S.

PLoS One. 2017 Dec 28;12(12):e0190147. doi: 10.1371/journal.pone.0190147. eCollection 2017.

36.

Diagnostic Yield of 2 Strategies for Adult Celiac Disease Identification in Primary Care.

Scoglio R, Trifirò G, Sandullo A, Marangio G, D'Agate C, Costa S, Pellegrino S, Alibrandi A, Aiello A, Currò G, Cuzzupè C, Comisi F, Amato S, Conti Nibali R, Oteri S, Magazzu G, Carroccio A; Sicilian Celiac Disease Study Group.

J Clin Gastroenterol. 2019 Jan;53(1):15-22. doi: 10.1097/MCG.0000000000000962.

PMID:
29256989
37.

The face in marfan syndrome: A 3D quantitative approach for a better definition of dysmorphic features.

Dolci C, Pucciarelli V, Gibelli DM, Codari M, Marelli S, Trifirò G, Pini A, Sforza C.

Clin Anat. 2018 Apr;31(3):380-386. doi: 10.1002/ca.23034. Epub 2017 Dec 23.

PMID:
29226593
38.

Interchangeability of biosimilar and biological reference product: updated regulatory positions and pre- and post-marketing evidence.

Trifirò G, Marcianò I, Ingrasciotta Y.

Expert Opin Biol Ther. 2018 Mar;18(3):309-315. doi: 10.1080/14712598.2018.1410134. Epub 2017 Nov 29. Review.

PMID:
29186988
39.

Comparing safety information of biosimilars with their originators: a cross-sectional analysis of European risk management plans.

Lepelaars LRA, Renda F, Pani L, Pimpinella G, Leufkens HGM, Trifirò G, Tafuri G, Mantel-Teeuwisse AK, Trotta F.

Br J Clin Pharmacol. 2018 Apr;84(4):738-763. doi: 10.1111/bcp.13454. Epub 2018 Jan 18.

40.

Impaired Central Pulsatile Hemodynamics in Children and Adolescents With Marfan Syndrome.

Grillo A, Salvi P, Marelli S, Gao L, Salvi L, Faini A, Trifirò G, Carretta R, Pini A, Parati G.

J Am Heart Assoc. 2017 Nov 7;6(11). pii: e006815. doi: 10.1161/JAHA.117.006815.

41.

Biological substantiation of antipsychotic-associated pneumonia: Systematic literature review and computational analyses.

Sultana J, Calabró M, Garcia-Serna R, Ferrajolo C, Crisafulli C, Mestres J, Trifirò' G.

PLoS One. 2017 Oct 27;12(10):e0187034. doi: 10.1371/journal.pone.0187034. eCollection 2017. Review.

42.

Prevalence of Use and Cost of Biological and Non-Biological Targeted Therapies for Cancer Treatment: A 5-Year Picture from Southern Italy.

Lucchesi S, Marcianò I, Panagia P, Intelisano R, Randazzo MP, Sgroi C, Altavilla G, Santarpia M, Adamo V, Franchina T, Ferraù F, Reitano P, Trifirò G.

Clin Drug Investig. 2018 Mar;38(3):269-278. doi: 10.1007/s40261-017-0591-3. Erratum in: Clin Drug Investig. 2017 Dec 30;:.

43.

Antidepressants and the risk of arrhythmia in elderly affected by a previous cardiovascular disease: a real-life investigation from Italy.

Biffi A, Rea F, Scotti L, Mugelli A, Lucenteforte E, Bettiol A, Chinellato A, Onder G, Vitale C, Agabiti N, Trifirò G, Roberto G, Corrao G; Italian Group for Appropriate Drug prescription in the Elderly (I-GrADE).

Eur J Clin Pharmacol. 2018 Jan;74(1):119-129. doi: 10.1007/s00228-017-2352-x. Epub 2017 Oct 18.

PMID:
29046942
44.

Calcium Channel Blockers in Secondary Cardiovascular Prevention and Risk of Acute Events: Real-World Evidence from Nested Case-Control Studies on Italian Hypertensive Elderly.

Bettiol A, Lucenteforte E, Vannacci A, Lombardi N, Onder G, Agabiti N, Vitale C, Trifirò G, Corrao G, Roberto G, Mugelli A, Chinellato A; Italian Group for Appropriate Drug prescription in the Elderly (I-GrADE).

Clin Drug Investig. 2017 Dec;37(12):1165-1174. doi: 10.1007/s40261-017-0576-2.

PMID:
28975522
45.

From Big Data to Smart Data for Pharmacovigilance: The Role of Healthcare Databases and Other Emerging Sources.

Trifirò G, Sultana J, Bate A.

Drug Saf. 2018 Feb;41(2):143-149. doi: 10.1007/s40264-017-0592-4.

PMID:
28840504
46.

Balancing the Need for Personalization of QT Correction and Generalization of Study Results: Going Beyond Thorough QT Studies.

Diemberger I, Raschi E, Trifirò G.

Clin Drug Investig. 2017 Oct;37(10):985-988. doi: 10.1007/s40261-017-0563-7. No abstract available.

PMID:
28831689
47.

Use of antihistamines and risk of ventricular tachyarrhythmia: a nested case-control study in five European countries from the ARITMO project.

Poluzzi E, Diemberger I, De Ridder M, Koci A, Clo M, Oteri A, Pecchioli S, Bezemer I, Schink T, Pilgaard Ulrichsen S, Boriani G, Sturkenboom MCJ, De Ponti F, Trifirò G.

Eur J Clin Pharmacol. 2017 Nov;73(11):1499-1510. doi: 10.1007/s00228-017-2317-0. Epub 2017 Aug 22.

PMID:
28831527
48.

Combining evidence from multiple electronic health care databases: performances of one-stage and two-stage meta-analysis in matched case-control studies.

La Gamba F, Corrao G, Romio S, Sturkenboom M, Trifirò G, Schink T, de Ridder M.

Pharmacoepidemiol Drug Saf. 2017 Oct;26(10):1213-1219. doi: 10.1002/pds.4280. Epub 2017 Aug 11. Erratum in: Pharmacoepidemiol Drug Saf. 2018 Dec;27(12):1434.

PMID:
28799196
49.

Treatment of Medication-Related Osteonecrosis of the Jaw and its Impact on a Patient's Quality of Life: A Single-Center, 10-Year Experience from Southern Italy.

Oteri G, Trifirò G, Peditto M, Lo Presti L, Marcianò I, Giorgianni F, Sultana J, Marcianò A.

Drug Saf. 2018 Jan;41(1):111-123. doi: 10.1007/s40264-017-0582-6.

PMID:
28766109
50.

Dementia prevalence and incidence in a federation of European Electronic Health Record databases: The European Medical Informatics Framework resource.

Perera G, Pedersen L, Ansel D, Alexander M, Arrighi HM, Avillach P, Foskett N, Gini R, Gordon MF, Gungabissoon U, Mayer MA, Novak G, Rijnbeek P, Trifirò G, van der Lei J, Visser PJ, Stewart R.

Alzheimers Dement. 2018 Feb;14(2):130-139. doi: 10.1016/j.jalz.2017.06.2270. Epub 2017 Jul 21.

Supplemental Content

Loading ...
Support Center